KQB198

· Kumquat Biosciences Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KQB198, covering 2026-02-06 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting [Phase 2]